Drug Type Small molecule drug |
Synonyms S-05520 |
Target |
Action blockers, inhibitors |
Mechanism VDCCs blockers(Voltage-gated calcium channel blockers), Symporters inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H16ClN3O3S |
InChIKeyNDDAHWYSQHTHNT-UHFFFAOYSA-N |
CAS Registry26807-65-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Essential Hypertension | Phase 3 | - | 04 Jul 2013 |
Phase 3 | 154 | ersbhqdkyb(igggfhxfck) = dsbdpfrkkk lfmlfjwtbt (vtdfwocaaf ) View more | Positive | 01 Jun 2018 | |||
ersbhqdkyb(igggfhxfck) = arquhfcsta lfmlfjwtbt (vtdfwocaaf ) View more |





